IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories Inc.

Bank of America Securities analyst Michael Ryskin maintained a Hold rating on Idexx Laboratories today and set a price target of $790.00. According...

Bank of America Securities Remains a Hold on Idexx Laboratories (IDXX)

In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Hold rating on Idexx Laboratories, with a price target ...

Bank of America Securities Reaffirms Their Hold Rating on Idexx Laboratories (IDXX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on aTyr Pharma (ATYR) and Idexx Laboratories (IDXX). ...

Market Cap	$50.50B	P/E Ratio	39.09
52W High	$769.98	52W Low	$427.70
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	17.5%	52W Position	41.1%
Overall Score	53	Value Score	35
Quality Score	71	Technical Score	54

EPS Current Est	$14.54	EPS Next Est	$16.35
EPS Growth Est	+12.4%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	IDXX	$568.30	-1.16%	539.02K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	IDXX	$568.30	-1.2%	539.02K
3
4
5
6

IDXX

IDXX

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get IDEXX Laboratories Inc. Data in Excel

Get IDEXX Laboratories Inc. Data in Excel